PUBLISHER: The Business Research Company | PRODUCT CODE: 1666438
PUBLISHER: The Business Research Company | PRODUCT CODE: 1666438
Bioinformatics services encompass a broad spectrum of computational tools, resources, and analyses applied in the realm of bioinformatics. These services involve scrutinizing connections between technical and biological variables within studies, encompassing tasks such as sample metadata assessment, data quality control, and standardization across samples.
The primary categories of bioinformatics services include sequencing services, data analysis, drug discovery services, differential gene expression analysis, database management, and various other specialized bioinformatics services. Sequencing services involve deciphering the exact sequence of nucleotides within a given sample. Specialized domains within bioinformatics services span medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The applications of these services are diverse, encompassing genomics, chemoinformatics, drug design, proteomics, transcriptomics, metabolomics, and other fields. End-users of bioinformatics services include academic institutes, research centers, hospitals, clinics, pharmaceutical and biotechnology companies, contract research organizations (CROs), and various other end-user entities.
The bioinformatics services market research report is one of a series of new reports from The Business Research Company that provides bioinformatics services market statistics, including bioinformatics services industry global market size, regional shares, competitors with a bioinformatics services market share, detailed bioinformatics services market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics services industry. This bioinformatics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics services market size has grown rapidly in recent years. It will grow from$4.15 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to genomic research advancements, rise in personalized medicine, pharmaceutical R&D investments, biological data explosion, government initiatives in healthcare, increasing adoption of next-generation sequencing (NGSs)
The bioinformatics services market size is expected to see rapid growth in the next few years. It will grow to $9.38 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to expanding role in clinical diagnostics, growing importance in agriculture and environmental sciences, increasing collaboration in research, rising demand in drug repurposing. Major trends in the forecast period include digital health initiatives, technological advancements in sequencing, ai and machine learning integration, cloud-based solutions, personalized medicine and genomic analysis, integration of blockchain for data security.
The growing adoption of information technology in the healthcare sector is anticipated to significantly enhance the bioinformatics services market in the future. This rise in technology usage has enabled healthcare professionals to elevate the quality of care they deliver to patients, enhance patient safety, improve operational efficiency, reduce costs, and foster better communication among healthcare providers. Bioinformatics services, which leverage computer science and statistics to analyze biological data, rely heavily on IT infrastructure. For example, a report from the National Center for Health Statistics, a U.S. government agency, indicated that in December 2022, 58.5% of adults in the U.S. turned to the Internet for health or medical information, 41.5% used it to connect with doctors or their offices, and 46.1% sought medical test results online. Consequently, the rising integration of information technology in healthcare is propelling the expansion of the bioinformatics services market in the coming years.
The rising demand for personalized medicine is anticipated to significantly drive the expansion of the bioinformatics services market in the future. Personalized medicine is an innovative healthcare approach that considers individual differences in patients' genetics, environments, and lifestyles. Bioinformatics plays a crucial role in personalized medicine by identifying genetic variations, predicting disease risk, analyzing genomic and proteomic data, and safeguarding sensitive health information. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is fueling the growth of the bioinformatics services market moving forward.
Technological advancements serve as a prominent trend shaping the bioinformatics services market, with companies leveraging innovative technologies to fortify their positions. An illustrative example is bitBiome Inc.'s July 2022 launch of the Enzyme Discovery service, leveraging the world's largest microbial genome database (MMGDB) and distinctive bioinformatics technologies. Employing their fundamental technology, bit-MAP, for microbial single-cell genome analysis, bitBiome's service analyzes the human microbiome and environmental bacteria, offering enzyme discovery services through unique bioinformatics and 3D structural modeling technologies.
Leading companies in the bioinformatics services sector prioritize introducing innovative bioinformatic tools offering advanced data solutions, particularly in epigenetic data analysis. FOXO Technologies Inc.'s July 2023 launch of 'Bioinformatics Services' exemplifies this focus, delivering a comprehensive platform equipped with cutting-edge tools for accelerated epigenetic data analysis. These tools significantly boost speed and accuracy in data results, contributing to the processing, analysis, and interpretation of complex disease-related data, thereby expediting research and enhancing comprehension in the field.
In May 2022, ZS, a US-based management consulting company, completed the acquisition of Intomics A/S for an undisclosed amount. This strategic move aims to expand and diversify ZS's portfolio by integrating deep data, scientific expertise, academia, technology, and artificial intelligence. The synergy resulting from this acquisition is expected to expedite drug discovery processes and enhance the probability of success for new pharmaceuticals. Intomics A/S, based in Europe, specializes in bioinformatics and systems biology, operating within the bioinformatics services market.
Major companies operating in the bioinformatics services market include QIAGEN Digital Insights, Thermo Fisher Scientific Inc., Illumina Inc., DNAnexus Inc., PerkinElmer Inc., Biomax Informatics AG, Life Technologies Corporation, BGI Group, Eurofins Scientific SE, NeoGenomics Laboratories Inc., CD Genomics Inc., MedGenome Labs Pvt. Ltd., Fios Genomics Ltd., Geneva Bioinformatics SA, GVK Biosciences Private Limited, Accelrys Inc., Macrogen Inc., GENEWIZ Inc., Source BioScience Limited, Microsynth AG, BaseClear B.V., DNASTAR Inc., GATC Biotech AG, Partek Incorporated, Seven Bridges Genomics Inc., Omixon Inc., BioTeam Inc., BioBam Bioinformatics S.L., Biomatters Limited, Genomatix GmbH, DNASTREAM Limited, Genalice B.V., Golden Helix Inc., Strand Life Sciences Private Limited
North America was the largest region in the bioinformatics services market in 2024. Europe is expected to be the fastest-growing region in the global bioinformatics services market report during the forecast period. The regions covered in the bioinformatics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the bioinformatics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The bioinformatics services market includes revenues earned by entities through single-cell analysis, proteomics analysis, metabolomics analysis, and epigenetics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioinformatics Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioinformatics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioinformatics services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.